Edward W Greeno

Professor, Medicine - Hematology, Oncology, Transplant

Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Expertise related to UN SDGs

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

Fingerprint

The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

3 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

8 Active
30 Finished

An open-label, randomised, multicentre, phase III study of irinotecanliposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine insubjects who have not previously received chemotherapy for metastatic adenocarcinom
Greeno, E. W.
Ipsen Innovation
3/24/20 → 3/31/25
Project: Research project
A Phase III Open-Label, Multi-Centre, Randomised Study Comparing NUC-1031 plus Cisplatin to Gemcitabine plus Cisplatin in Patients with Previously Untreated Locally Advanced orMetastatic Biliary Tract Cancer
Greeno, E. W.
NUCANA, INC
12/12/19 → 12/31/24
Project: Research project
A Phase 1, Open-Label, Dose-Escalation and Expansion, Safety and TolerabilityStudy of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
Greeno, E. W.
Incyte Corporation
4/12/19 → 4/30/21
Project: Research project
A Randomized, Phase 3 Study of Eryaspase in Combination with Chemotherapy versus Chemotherapy Alone as Second-Line Treatment in Patients with Pancreatic AdenocarcinomaTRYbeCA-1 - Trial of Eryaspase in pancreatic Cancer
Greeno, E. W.
ERYTECH PHARMA, INC
10/1/18 → 10/30/22
Project: Research project
Phase 1-2 Study of ADI-PEG 20 plus FOLFOX in Subjects withAdvanced Gastrointestinal Malignancies
Greeno, E. W.
Polaris Pharmaceuticals, Inc.
12/1/17 → 11/30/22
Project: Research project

28 Article
1 Comment/debate
1 Letter
1 Review article

A phase I, dose escalation, single dose trial of oral attenuated salmonella typhimurium containing human IL-2 in patients with metastatic gastrointestinal cancers
Gniadek, T. J., Augustin, L., Schottel, J., Leonard, A., Saltzman, D., Greeno, E. & Batist, G., Sep 1 2020, In: Journal of Immunotherapy. 43, 7, p. 217-221 5 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Hurwitz, H., Van Cutsem, E., Bendell, J., Hidalgo, M., Li, C. P., Salvo, M. G., Macarulla, T., Sahai, V., Sama, A., Greeno, E. W., Yu, K. H., Verslype, C., Dawkins, F., Walker, C., Clark, J. & O’Reilly, E. M., Aug 1 2018, In: Investigational New Drugs. 36, 4, p. 683-695 13 p.
Research output: Contribution to journal › Article › peer-review

Open Access
27 Scopus citations
Development of peripheral neuropathy and its association with survival during treatment with nab-paclitaxel plus gemcitabine for patients with metastatic adenocarcinoma of the pancreas: A subset analysis from a randomised phase III trial (MPACT)
Goldstein, D., Von Hoff, D. D., Moore, M., Greeno, E., Tortora, G., Ramanathan, R. K., Macarulla, T., Liu, H., Pilot, R., Ferrara, S. & Lu, B., Jan 2016, In: European Journal of Cancer. 52, p. 85-91 7 p.
Research output: Contribution to journal › Article › peer-review

Open Access
20 Scopus citations
RNA sequencing of pancreatic adenocarcinoma tumors yields novel expression patterns associated with long-term survival and reveals a role for ANGPTL4
Kirby, M. K., Ramaker, R. C., Gertz, J., Davis, N. S., Johnston, B. E., Oliver, P. G., Sexton, K. C., Greeno, E. W., Christein, J. D., Heslin, M. J., Posey, J. A., Grizzle, W. E., Vickers, S. M., Buchsbaum, D. J., Cooper, S. J. & Myers, R. M., Oct 1 2016, In: Molecular Oncology. 10, 8, p. 1169-1182 14 p.
Research output: Contribution to journal › Article › peer-review

Open Access
23 Scopus citations
Appropriateness of systemic treatments in unresectable metastatic well-differentiated pancreatic neuroendocrine tumors
Strosberg, J. R., Fisher, G. A., Benson, A. B., Anthony, L. B., Arslan, B., Gibbs, J. F., Greeno, E., Iyer, R. V., Kim, M. K., Maples, W. J., Philip, P. A., Wolin, E. M., Cherepanov, D. & Broder, M. S., Feb 28 2015, In: World journal of gastroenterology. 21, 8, p. 2450-2459 10 p.
Research output: Contribution to journal › Article › peer-review
12 Scopus citations

Record drop in cancer deaths may reflect a series of treatment breakthroughs
Douglas Yee & Edward W Greeno
1/8/20 → 1/9/20
3 items of Media coverage
Press/Media: Expert Comment